Healthcare provider profile · identity verified

Michael Robert Jordan, M.D.

Family Practice · WILLIAMSVILLE, NY · NPI 1952456808

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	404	139
Atorvastatin Calcium	Atorvastatin Calcium	399	168
Rosuvastatin Calcium	Rosuvastatin Calcium	380	164
Amlodipine Besylate	Amlodipine Besylate	317	137
Gabapentin	Gabapentin	232	86
Fluticasone Propionate	Fluticasone Propionate	218	110
Duloxetine Hcl	Duloxetine Hcl	207	78
Lisinopril	Lisinopril	193	71
Trazodone Hcl	Trazodone Hcl	177	81
Omeprazole	Omeprazole	171	73
Metoprolol Succinate	Metoprolol Succinate	155	66
Losartan Potassium	Losartan Potassium	153	56
Methylprednisolone	Methylprednisolone	132	114
Famotidine	Famotidine	125	52
Hydrochlorothiazide	Hydrochlorothiazide	121	48
Metformin Hcl Er	Metformin Hcl	114	57
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	110	31
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	109	43
Escitalopram Oxalate	Escitalopram Oxalate	108	42
Azelastine Hcl	Azelastine Hcl	107	61
Pravastatin Sodium	Pravastatin Sodium	102	51
Ozempic	Semaglutide	97	26
Tamsulosin Hcl	Tamsulosin Hcl	86	40
Eliquis	Apixaban	84	31
Bupropion Xl	Bupropion Hcl	83	36
Mounjaro	Tirzepatide	83	13
Meloxicam	Meloxicam	79	43
Furosemide	Furosemide	77	32
Synthroid	Levothyroxine Sodium	77	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	35
Albuterol Sulfate Hfa	Albuterol Sulfate	71	39
Potassium Chloride	Potassium Chloride	70	29
Xarelto	Rivaroxaban	58	18
Allopurinol	Allopurinol	57	28
Atenolol	Atenolol	57	24
Pantoprazole Sodium	Pantoprazole Sodium	57	25
Prednisone	Prednisone	55	30
Sertraline Hcl	Sertraline Hcl	53	23
Tramadol Hcl	Tramadol Hcl	53	19
Alprazolam	Alprazolam	52	21
Simvastatin	Simvastatin	51	21
Alendronate Sodium	Alendronate Sodium	50	19
Metformin Hcl	Metformin Hcl	50	23
Mirtazapine	Mirtazapine	48	16
Glipizide Er	Glipizide	47	22
Doxycycline Hyclate	Doxycycline Hyclate	46	39
Trulicity	Dulaglutide	44	15
Clonazepam	Clonazepam	40	11
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	35	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	16
Tizanidine Hcl	Tizanidine Hcl	34	14
Baclofen	Baclofen	33	12
Clopidogrel	Clopidogrel Bisulfate	33	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	11
Buspirone Hcl	Buspirone Hcl	32	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	32	suppressed
Benazepril Hcl	Benazepril Hcl	31	15
Pregabalin	Pregabalin	31	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	30	27
Carvedilol	Carvedilol	29	12
Enalapril Maleate	Enalapril Maleate	29	suppressed
Cephalexin	Cephalexin	28	18
Montelukast Sodium	Montelukast Sodium	28	13
Triamcinolone Acetonide	Triamcinolone Acetonide	28	26
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	25
Lorazepam	Lorazepam	27	20
Azithromycin	Azithromycin	26	25
Metoprolol Tartrate	Metoprolol Tartrate	26	16
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	25	25
Myrbetriq	Mirabegron	25	14
Ramelteon	Ramelteon	24	14
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	13
Terazosin Hcl	Terazosin Hcl	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	16
Propranolol Hcl Er	Propranolol Hcl	22	suppressed
Spironolactone	Spironolactone	22	12
Valsartan	Valsartan	22	12
Celecoxib	Celecoxib	21	11
Colchicine	Colchicine	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Chlorthalidone	Chlorthalidone	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Naltrexone Hcl	Naltrexone Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Clonidine	Clonidine	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Brilinta	Ticagrelor	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Finasteride	Finasteride	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Trospium Chloride	Trospium Chloride	15	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	11
Propranolol Hcl	Propranolol Hcl	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Diazepam	Diazepam	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Nyamyc	Nystatin	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Clotrimazole	Clotrimazole	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error